RxDoctor Payments Data

Kristin Jarzombek, MD

Interventional Pain Medicine · Kyle, TXNPI 1811308794

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 46.6% of the total. 2025 is the largest year on record at $28,817, more than ten times the $2,414 reported in 2019. Among interventional pain medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$73,664in general payments, 2019–2025

Across 1,035 payments — averaging $71.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$34K
  • Spinal Simplicity, LLC$33K
  • Medtronic$3K
  • Boston Scientific$1K
  • Nevro Corp.$863
  • Foundation Fusion Solutions, LLC$730
  • plus $1K from 9 others

What the payments were for

  • Consulting fees$11,90016%
  • Speaking & faculty fees$5,0617%
  • Travel & lodging$12,22117%
  • Food & beverage$37,70951%
  • Education$6,6399%
  • Entertainment$1340%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,664 in reported general payments places this provider in the 90th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$409,051
Medicare patients
498
Services billed
4,826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen983$23,375
Gabapentin581$6,489
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen272$6,333
Pregabalin323$5,324
OxycontinOxycodone Hcl11$2,898
Tizanidine Hcl295$2,735
Lidocaine37$2,364
Cyclobenzaprine Hcl202$2,136
Methocarbamol122$2,095
Tramadol Hcl232$1,706
Morphine Sulfate ErMorphine Sulfate80$1,579
Oxycodone Hcl121$1,494
Acetaminophen-CodeineAcetaminophen With Codeine41$939
Duloxetine Hcl58$846
Baclofen49$763

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Kyle

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →